The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
The global Osteosarcoma market size is expected to reach US$ 677.7 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Osteosarcoma in various end use industries.
The expanding demands from the Hospital, Clinic and Others,, are propelling Osteosarcoma market. Intramedullary Osteosarcoma, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Juxtacortical Osteosarcoma segment is estimated at % CAGR for the next seven-year period.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteosarcoma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteosarcoma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteosarcoma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteosarcoma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteosarcoma covered in this report include Pfizer, Spectrum Pharmaceuticals, Hikma Pharmaceuticals, Baxter, Isofol, Advaxis, Bellicum Pharmaceuticals and Novartis, etc.
The global Osteosarcoma market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Pfizer
- Spectrum Pharmaceuticals
- Hikma Pharmaceuticals
- Baxter
- Isofol
- Advaxis
- Bellicum Pharmaceuticals
- Novartis
Global Osteosarcoma market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteosarcoma market, Segment by Type:
- Intramedullary Osteosarcoma
- Juxtacortical Osteosarcoma
- Extraskeletal Osteosarcoma
Global Osteosarcoma market, by Application
- Hospital
- Clinic
- Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Osteosarcoma companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Osteosarcoma
1.1 Osteosarcoma Market Overview
1.1.1 Osteosarcoma Product Scope
1.1.2 Osteosarcoma Market Status and Outlook
1.2 Global Osteosarcoma Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Osteosarcoma Market Size by Region (2018-2029)
1.4 Global Osteosarcoma Historic Market Size by Region (2018-2023)
1.5 Global Osteosarcoma Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Osteosarcoma Market Size (2018-2029)
1.6.1 North America Osteosarcoma Market Size (2018-2029)
1.6.2 Europe Osteosarcoma Market Size (2018-2029)
1.6.3 Asia-Pacific Osteosarcoma Market Size (2018-2029)
1.6.4 Latin America Osteosarcoma Market Size (2018-2029)
1.6.5 Middle East & Africa Osteosarcoma Market Size (2018-2029)
2 Osteosarcoma Market by Type
2.1 Introduction
2.1.1 Intramedullary Osteosarcoma
2.1.2 Juxtacortical Osteosarcoma
2.1.3 Extraskeletal Osteosarcoma
2.2 Global Osteosarcoma Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Osteosarcoma Historic Market Size by Type (2018-2023)
2.2.2 Global Osteosarcoma Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Osteosarcoma Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Osteosarcoma Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Osteosarcoma Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Osteosarcoma Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Osteosarcoma Revenue Breakdown by Type (2018-2029)
3 Osteosarcoma Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Osteosarcoma Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Osteosarcoma Historic Market Size by Application (2018-2023)
3.2.2 Global Osteosarcoma Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Osteosarcoma Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Osteosarcoma Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Osteosarcoma Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Osteosarcoma Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Osteosarcoma Revenue Breakdown by Application (2018-2029)
4 Osteosarcoma Competition Analysis by Players
4.1 Global Osteosarcoma Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteosarcoma as of 2022)
4.3 Date of Key Players Enter into Osteosarcoma Market
4.4 Global Top Players Osteosarcoma Headquarters and Area Served
4.5 Key Players Osteosarcoma Product Solution and Service
4.6 Competitive Status
4.6.1 Osteosarcoma Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Osteosarcoma Products, Services and Solutions
5.1.4 Pfizer Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Spectrum Pharmaceuticals
5.2.1 Spectrum Pharmaceuticals Profile
5.2.2 Spectrum Pharmaceuticals Main Business
5.2.3 Spectrum Pharmaceuticals Osteosarcoma Products, Services and Solutions
5.2.4 Spectrum Pharmaceuticals Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.2.5 Spectrum Pharmaceuticals Recent Developments
5.3 Hikma Pharmaceuticals
5.3.1 Hikma Pharmaceuticals Profile
5.3.2 Hikma Pharmaceuticals Main Business
5.3.3 Hikma Pharmaceuticals Osteosarcoma Products, Services and Solutions
5.3.4 Hikma Pharmaceuticals Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.3.5 Baxter Recent Developments
5.4 Baxter
5.4.1 Baxter Profile
5.4.2 Baxter Main Business
5.4.3 Baxter Osteosarcoma Products, Services and Solutions
5.4.4 Baxter Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.4.5 Baxter Recent Developments
5.5 Isofol
5.5.1 Isofol Profile
5.5.2 Isofol Main Business
5.5.3 Isofol Osteosarcoma Products, Services and Solutions
5.5.4 Isofol Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.5.5 Isofol Recent Developments
5.6 Advaxis
5.6.1 Advaxis Profile
5.6.2 Advaxis Main Business
5.6.3 Advaxis Osteosarcoma Products, Services and Solutions
5.6.4 Advaxis Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.6.5 Advaxis Recent Developments
5.7 Bellicum Pharmaceuticals
5.7.1 Bellicum Pharmaceuticals Profile
5.7.2 Bellicum Pharmaceuticals Main Business
5.7.3 Bellicum Pharmaceuticals Osteosarcoma Products, Services and Solutions
5.7.4 Bellicum Pharmaceuticals Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.7.5 Bellicum Pharmaceuticals Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Osteosarcoma Products, Services and Solutions
5.8.4 Novartis Osteosarcoma Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
6 North America
6.1 North America Osteosarcoma Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Osteosarcoma Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Osteosarcoma Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Osteosarcoma Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Osteosarcoma Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Osteosarcoma Market Dynamics
11.1 Osteosarcoma Industry Trends
11.2 Osteosarcoma Market Drivers
11.3 Osteosarcoma Market Challenges
11.4 Osteosarcoma Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
